Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

Item 1.01. Entry into a Material Definitive Agreement.

On November 7, 2012, AmSurg Corp. (the "Company") entered into an amendment to
its Revolving Credit Agreement, dated May 28, 2010, as amended (the "Revolving
Credit Agreement"), with the lenders party thereto to (i) increase the Leverage
Ratio (as defined in the Revolving Credit Agreement) covenant from 3.25x to
3.75x, (ii) be permitted to offer, issue and sell up to an aggregate principal
amount of $275 million of senior unsecured notes (the "Senior Notes"), (iii) be
permitted to incur additional senior secured indebtedness subject to the
satisfaction of an incurrence test of the Secured Leverage Ratio (as defined in
the Revolving Credit Agreement) on a pro forma basis and (iv) be permitted to
incur additional unsecured indebtedness subject to the satisfaction of an
incurrence test of the Leverage Ratio on a pro forma basis. The effectiveness
of the amendment is conditioned upon, among other things, the issuance of the
Senior Notes.

On November 7, 2012, the Company also amended its Note Purchase
Agreement, dated May 28, 2010, as amended (the "Note Purchase Agreement"), with
the noteholders named therein to (i) increase the Leverage Ratio (as defined in
the Note Purchase Agreement) covenant from 3.25x to 3.75x, (ii) be permitted to
offer, issue and sell the Senior Notes, (iii) be permitted to incur additional
senior secured indebtedness subject to the satisfaction of an incurrence test of
the Secured Leverage Ratio (as defined in the Note Purchase Agreement) on a pro
forma basis, (iv) be permitted to incur additional unsecured indebtedness
subject to the satisfaction of an incurrence test of the Leverage Ratio on a pro
forma basis, and (v) increase the per annum interest rate applicable to the
Notes (as defined in the Note Purchase Agreement) by 2.00%. The increase in the
interest rate applicable to the Notes is effective November 7, 2012, and the
other amendments to the Note Purchase Agreement are conditioned upon, among
other things, the issuance of the Senior Notes.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.

On November 7, 2012, the Company entered into an amendment to its
Revolving Credit Agreement, the material terms and conditions of which are
described in Item 1.01 of this Current Report on Form 8-K and are incorporated
by reference into this Item 2.03.

On November 7, 2012, the Company entered into an amendment to its Note
Purchase Agreement, the material terms and conditions of which are described in
Item 1.01 of this Current Report on Form 8-K and are incorporated by reference
into this Item 2.03.

Item 8.01. Other Events

On November 7, 2012, AmSurg Corp. issued a press release, the text of which is
set forth as Exhibit 99, regarding the proposed private offering of $250 million
in aggregate principal amount of Senior Notes.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed as part of this report: